DANVERS, Mass.–(BUSINESS WIRE)–Abiomed (NASDAQ:ABMD) announces the U.S. FDA has approved the expansion of the Impella 5.0 and Impella LD PMA labeling for the treatment of cardiogenic shock. The expansion extends the duration of support for each pump from 6 days to 14 days. The Impella 5.0 and the Impella LD are forward flow heart pumps […]
Rhythm
FDA Grants First Ever Clearance For Six-Lead Personal ECG Device
MOUNTAIN VIEW, Calif., May 13, 2019 /PRNewswire/ — AliveCor, the leader in FDA-cleared consumer electrocardiogram technology (ECG), today announced its third FDA clearance in three months, making KardiaMobile 6L the world’s first available six-lead personal ECG device. This highly anticipated clearance gives patients and their physicians an even more detailed view into patients’ […]
NEW STUDIES HIGHLIGHT UNDERUSE OF IMPLANTABLE CARDIAC DEVICES
DUBLIN and SAN FRANCISCO – May 10, 2019 – Three new studies show that patients who are medically indicated for implantable heart devices, including implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy (CRT), often do not receive needed therapy. The findings underscore gender and race treatment disparities, as well as a […]
CardioFocus Announces Impressive Results From Pivotal Confirmatory Study With The Breakthrough HeartLight® X3 System
MARLBOROUGH, Mass., May 10, 2019 /PRNewswire/ — CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), today announced the presentation of results from its pivotal confirmatory study evaluating the HeartLight X3 System for the treatment of AFib. The results, which demonstrated superior procedural times and impressive procedural […]
Stereotaxis Announces Next Generation Robotic Magnetic Navigation System and Imaging System
Innovative robotic surgery system, Stereotaxis Genesis™ RMN, enriches robotic magnetic navigation with increased efficiency, reduced size, and enhanced lab experience Genesis RMN System to be available in combination with Stereotaxis Imaging Model S, a next-generation x-ray system offered as part of a complete robotic electrophysiology lab solution Combined technologies greatly […]
Philips announces collaboration with Medtronic to further advance the image-guided treatment of atrial fibrillation
May 9, 2019 Philips’ integrated solution will combine the unique KODEX-EPD dielectric imaging and navigation system, dielectric imaging sensors, clinical software, and services to support cryoablation procedures performed with the Medtronic Arctic Front Advance™ cryoablation technology Amsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today announced a collaboration with Medtronic to further advance […]
Duration of External ECG Monitoring is Critical to Detecting Atrial Fibrillation
MINNEAPOLIS, May 9, 2019 /PRNewswire/ — Preventice Solutions announced today the presentation of data showing the critical impact the length of the monitoring period has when using ambulatory remote ECG monitoring to detect atrial fibrillation (AF). While the Preventice BodyGuardian® Remote Monitoring System has the capability and reimbursement to support patient monitoring for […]
Acutus Medical Expands AFib Offerings; Announces Strategic Acquisition and New Partnerships in Monitoring and Therapy
SAN FRANCISCO, May 9, 2019 /PRNewswire/ — Today at the 40th annual Heart Rhythm Scientific Sessions, Acutus Medical announced the agreement to acquire Rhythm Xience, Inc., and new strategic partnerships with Peerbridge Health, Cardiac Designs and MedFact. Acutus’ expanded portfolio builds on the organization’s unprecedented mapping and visualization technology platform. Acutus is committed to helping […]
Stereotaxis and Osypka Enter Strategic Collaboration to Advance Robotic Catheter Technology
Development of next generation robotically-navigated magnetic ablation catheter fully owned by Stereotaxis Catheter designed to enhance patient care, improve therapy delivery, simplify catheter navigation, and strengthen commitment to open ecosystem Entered into additional business agreements to support a long-term broad collaboration in electrophysiology ST. LOUIS and RHEINFELDEN, Germany, May 09, […]
BIOSENSE WEBSTER ANNOUNCES INITIAL RESULTS FROM FIRST IN-HUMAN STUDY OF NOVEL HIGH POWER-SHORT DURATION ABLATION CATHETER FOR ATRIAL FIBRILLATION
Researchers Report QDOT MICRO Radiofrequency Ablation Catheter Demonstrates Safety and Achieves Pulmonary Vein Isolation with Shorter Procedure and Fluoroscopy Times SAN FRANCISCO — May 9, 2019 – Johnson & Johnson Medical Devices Companies* today announced that Biosense Webster, Inc.’s QDOT MICRO, a novel catheter that facilitates high power-short duration radiofrequency […]



